Jardiance Cost in 2026: Prices & How to Save

If your pharmacist just quoted you somewhere north of $600 for a one-month supply of Jardiance, you read the receipt right. A drug you take once a day, a tiny tablet, and it costs more than a car payment. For a lot of people managing type 2 diabetes or heart failure, that number is the whole problem.

Here's what Jardiance actually costs in 2026, why the price is stuck where it is, and the specific moves that bring it down — without touching your insurance.

How much does Jardiance cost without insurance?

Jardiance is the brand name for empagliflozin, an SGLT2 inhibitor made by Boehringer Ingelheim and Eli Lilly. It's prescribed for type 2 diabetes, heart failure, and chronic kidney disease, and most people take one tablet a day.

At a US retail pharmacy, paying full sticker price, a 30-tablet supply lands in this range:

Strength	Typical 30-day cash price	Roughly per year
Jardiance 10 mg	$600 – $750	~$8,400
Jardiance 25 mg	$650 – $830	~$9,000+

A detail that surprises people: the 10 mg and 25 mg pills are priced almost identically. You're paying for the tablet, not the dose. So splitting or stepping down a dose to save money usually doesn't work the way it does with some other medications — and you shouldn't change a dose without your prescriber anyway.

Prices also swing by pharmacy. The same prescription can be $610 at one chain and $790 down the street, which is why checking more than one counter is worth the ten minutes.

Why is Jardiance so expensive?

One word: monopoly. Not in a sinister sense — that's just how brand-name drug pricing works while patents hold. Jardiance has no generic competitor in the US, so Boehringer Ingelheim and Lilly set the price and there's nothing pulling it down.

Empagliflozin came to market in 2014 and turned out to do far more than lower blood sugar. Large trials showed it cut cardiovascular death and slowed kidney decline, which expanded who gets prescribed it and gave the manufacturers room to keep the price high. A drug that protects the heart and kidneys is a drug people stay on for years.

The patent thicket is the other half of the story. Beyond the core compound patent, there are layered patents on formulations and uses, plus regulatory exclusivities tied to newer approved indications. Each one is a separate wall a generic maker has to get past.

Is there a generic for Jardiance yet?

Not from a US retail pharmacy, no — and not in 2026 so far.

The FDA has handed out tentative approvals to several generic empagliflozin makers, which means the agency agrees the copies meet the standard — they just can't be sold in the US until the patents clear or get knocked out in court. Estimates for a full US launch cluster around 2026 to 2028, ongoing litigation could push some products later, and a few combination versions carry patents stretching toward 2034.

Here's the wrinkle worth knowing: generic empagliflozin is already approved and sold in other countries, so licensed cross-border pharmacies can fill it legitimately for cash payers right now. That's a different animal from the sketchy "generic Jardiance" ads you'll see online. We laid out the full timeline in our guide to whether there's a generic for Jardiance.

Jardiance cost with insurance and Medicare

If you have commercial insurance, your out-of-pocket cost depends on your plan's formulary tier and deductible. Jardiance usually sits on a higher tier, so a copay of $30 to $100 a month is common once any deductible is met — but plenty of plans leave you paying full price until you hit that deductible early in the year.

Medicare changed meaningfully for 2026. Under the Inflation Reduction Act, total out-of-pocket spending on covered Part D drugs is now capped at $2,100 for the year (up from $2,000 in 2025). Once your combined deductibles, copays, and coinsurance reach $2,100, your plan pays 100% of covered drugs for the rest of the year. For someone on Jardiance plus a few other prescriptions, that cap is reachable, and it puts a hard ceiling on a previously bottomless bill. You can also spread that $2,100 across the year in monthly installments through the Medicare Prescription Payment Plan.

The cap only helps if Jardiance is on your plan's formulary, so check that during open enrollment.

How to save on Jardiance without insurance

Most people actually live here — uninsured, underinsured, or stuck in a deductible. A few approaches genuinely move the number.

Compare pharmacy cash prices and discount cards

Third-party discount cards (the GoodRx and SingleCare type) negotiate cash rates that often beat the pharmacy's sticker price, bringing Jardiance down to roughly $355 to $400 a month at participating pharmacies. They cost nothing to use, and you can't combine them with insurance, but for a cash payer they're an easy first stop. Prices vary by card and location, so it pays to compare a couple before you fill.

Ask about a 90-day supply

Buying three months at once frequently lowers the per-month cost and cuts dispensing fees. If your prescriber writes a 90-day prescription, you also skip two trips to the pharmacy. Ask whether the cash or card price per pill drops at the larger quantity — it usually does.

Look at licensed cross-border cash-pay pharmacies

Brand-name Jardiance made by the same manufacturer is priced very differently outside the US. In Canada, a 30-tablet supply commonly lists between $106 and $175, and the 10 mg and 25 mg strengths are often the same price.

The bigger saver is the generic. Because empagliflozin already has an approved generic in other countries, licensed cross-border cash-pay pharmacies can fill it for far less than the US brand — often around $140 for a 100-tablet supply, which pencils out to roughly $42 a month. Same active ingredient, small fraction of the price.

This is the gap a cash-pay health network like CanAmerica Plus is built around: connecting US patients with licensed, verified pharmacies so the cash price reflects what the rest of the world pays. For a drug you'll take for years, the difference between $650 and $50 a month adds up to thousands of dollars a year.

Talk to your doctor about therapeutic alternatives

Jardiance isn't the only SGLT2 inhibitor. If cost is forcing your hand, it's a conversation worth having with your prescriber — not a switch to make on your own, since these drugs differ in their approved uses and evidence.

Farxiga (generic name dapagliflozin) is the closest cousin, also approved for diabetes, heart failure, and kidney disease. Invokana (canagliflozin) and Steglatro are others in the class. None has a cheap US generic yet either, but cash prices differ, and one may fit your situation and budget better.

If you take a combination product — Synjardy (empagliflozin plus metformin) or Glyxambi (empagliflozin plus linagliptin) — the math is worth revisiting too, since buying the two components separately sometimes costs less.

Jardiance vs. the alternatives: a cost snapshot

For readers weighing options, here's roughly how the SGLT2 class compares on US cash price. Treat these as ballpark figures — actual prices shift by pharmacy and over time.

Medication	Class	Approx. US cash price/month	US generic?
Jardiance (empagliflozin)	SGLT2 inhibitor	$600 – $830	No
Farxiga (dapagliflozin)	SGLT2 inhibitor	$600 – $700	No
Invokana (canagliflozin)	SGLT2 inhibitor	$600 – $700	No
Steglatro (ertugliflozin)	SGLT2 inhibitor	$400 – $500	No

The takeaway isn't that one is clearly cheapest for everyone — it's that the whole class is expensive in the US while patents hold, and the bigger savings usually come from where you buy rather than which one you buy. Effectiveness and your specific conditions should drive the choice; let your doctor weigh in before anything changes.

The bottom line

Jardiance costs roughly $600 to $830 a month at a US pharmacy in 2026, there's no generic to rescue you yet, and the price isn't dropping on its own. What you can control is how you buy it: compare cash prices and discount cards, ask about 90-day fills, look into licensed cross-border cash-pay pharmacies for the brand-name product, and ask your doctor whether a different SGLT2 inhibitor makes sense for you. Start by checking the cash price on CanAmerica Plus and comparing it against what you're paying now.

Frequently asked questions

Why is Jardiance so expensive without insurance?

Because it has no generic competition in the US. Patents and regulatory exclusivities let Boehringer Ingelheim and Lilly set the price, and a drug proven to protect the heart and kidneys keeps strong demand. Until a generic empagliflozin actually launches, the brand price holds.

How much does Jardiance cost per month in 2026?

About $600 to $830 for a 30-tablet supply at a US retail pharmacy, depending on the pharmacy and strength. Discount cards can bring that to roughly $355 to $400, and licensed cross-border cash-pay pharmacies often list brand-name Jardiance closer to $110 to $175 — with generic empagliflozin lower still.

Is there a cheaper alternative to Jardiance?

Other SGLT2 inhibitors like Farxiga, Invokana, and Steglatro treat overlapping conditions and have different cash prices. None has a cheap US generic yet, so the savings are modest. Ask your prescriber before switching, since these drugs aren't interchangeable for every use.

How much does Jardiance cost with Medicare in 2026?

It depends on your Part D plan, but total out-of-pocket spending on covered drugs is capped at $2,100 for 2026. Once you hit that, your plan covers 100% of covered medications for the rest of the year — as long as Jardiance is on your plan's formulary.

Does the 25 mg cost more than the 10 mg?

Barely, if at all. Both strengths are single once-daily tablets and are usually priced almost the same. Paying for a higher dose rarely costs much more, and you should never change your dose to save money without talking to your doctor.

---

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment. Pricing information is current as of the publication date but may change. Verify pricing directly before making purchasing decisions.